Chloroquine sensitivity of Plasmodium vivax in Thailand.
Chloroquine has been the standard treatment for Plasmodium vivax malaria for more than 40 years in most regions of the world. Recently, however, chloroquine-resistant P. vivax has been reported from Oceania, several parts of Asia, and South America. In order to assess the situation in Thailand, 886...
Main Authors: | Looareesuwan, S, Wilairatana, P, Krudsood, S, Treeprasertsuk, S, Singhasivanon, P, Bussaratid, V, Chokjindachai, W, Viriyavejakul, P, Chalermrut, K, Walsh D, S, White, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1999
|
Similar Items
-
Clinical trial of oral artesunate with or without high-dose primaquine for the treatment of vivax malaria in Thailand.
by: Silachamroon, U, et al.
Published: (2003) -
Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial.
by: Phyo, A, et al.
Published: (2011) -
Chloroquine resistance in Plasmodium vivax.
by: Baird, J
Published: (2004) -
Plasmodium vivax trophozoites insensitive to chloroquine.
by: Sharrock, W, et al.
Published: (2008) -
Chloroquine sensitive Plasmodium falciparum and P. vivax in central Java, Indonesia.
by: Baird, J, et al.
Published: (1996)